Drug Name |
Valrubicin |
Drug ID |
BADD_D02330 |
Description |
Valrubicin (N-trifluoroacetyladriamycin-14-valerate) is a chemotherapy drug commonly marketed under the trade name VALSTAR. It is a semisynthetic analog of the [doxorubicin], which is an anthracycline drug. Used in the treatment of the bladder cancer, valrubicin is administered by direct infusion into the bladder. |
Indications and Usage |
For the treatment of cancer of the bladder. |
Marketing Status |
Prescription |
ATC Code |
L01DB09 |
DrugBank ID |
DB00385
|
KEGG ID |
D02697
|
MeSH ID |
C016163
|
PubChem ID |
454216
|
TTD Drug ID |
D07IPB
|
NDC Product Code |
27831-005; 67979-001; 72027-005; 77391-005 |
Synonyms |
valrubicin | N-trifluoroacetyladriamycin 14-valerate | Valtaxin | Valstar | AD 32 | AD-32 | NSC-246131 |